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Reductions in populations of both Pre-B cell (Hardy fractions D) and Pro-B cells (Hardy fractions
B–C) have been described in association with murine lupus. Recent studies of B cell populations, based
on evaluation of B cell differentiation markers, now allow the enumeration and enrichment of other
stage speciﬁc precursor cells. In this study we report detailed analysis of the ontogeny of B cell lineage
subsets in New Zealand black (NZB) and control strains of mice. Our data suggest that B cell
development in NZB mice is partially arrested at the fraction A Pre–Pro B cell stage. This arrest at the
Pre–Pro B cell stage is secondary to prolonged lifespan and greater resistance to spontaneous
apoptosis. In addition, expression of the gene encoding the critical B cell development transcription
factor BSAP is reduced in the Pre–Pro B cell stage in NZB mice. This impairment may inﬂuence
subsequent B cell development to later stages, and thereby accounts for the down-regulation of the B
cell receptor component Iga (mb-1). Furthermore, levels of expression of the Rug2, l5 and Igb (B29)
genes are also reduced in Pre–Pro B cells of NZB mice. The decreased frequency of precursor B cells
in the Pre–Pro B cell population occurs at the most primitive stage of B cell differentiation.
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INTRODUCTION
Rapid progress is being made in deﬁning lineage speciﬁc
precursor cells that are intermediates in the pathway of
B cell differentiation (Payne et al., 1999; Akashi et al.,
2000). Development of mature B cells from multipotential
stem cells is accompanied by qualitative and/or quanti-
tative differences in the expression of cell surface mole-
cules. Such differences permit enumeration, depletion and
enrichment of stage-speciﬁc precursor cells. Merchant
et al.(1995; 1996) fractionated bone marrow cells (BMC)
from lupus-prone mice according to stage speciﬁc
fractions (Hardy and Hayakawa, 1991) and demonstrated
an age-dependent reduction of both Pre- (Fr. D) and Pro-B
cells (Fr. B–C) in the bone marrow (BM). Herein, we
performed a detailed study of the ontogeny of each sub-
stage speciﬁc lineage of B cells from New Zealand black
(NZB) mice. Our data reveal an accumulation, rather than
a reduction, of the most immature B lineage cells, referred
to as Pre–Pro B cells. Furthermore, the increased
frequency of Pre–Pro B cells was secondary to a
decreased rate of apoptosis. Thus, the decreased frequency
of precursor B cells in NZB mice occurs at the most
primitive stage of B cell differentiation may be secondary
to abnormalities in the gene(s) that control B cell lineage
differentiation.
MATERIALS AND METHODS
Mice and Cell Preparation
Female NZB/BlnJ, BALB/CJ, C3H/HeJ, C57BL/6J mice,
aged 1–8 months, were obtained from Jackson Laboratory
(Bar Harbor, ME) and subsequently maintained by the
Animal Resource Service of the University of California
at Davis. BMC were obtained by ﬂushing two femurs and
tibiae with PBS containing 0.2% bovine serum albumin
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were washed and viable cells quantitated and conﬁrmed
using trypan blue exclusion. The data presented in all
experiments was replicated in three separate experiments
using 3–4 mice per group, unless otherwise noted.
Antibodies
FITC-, PE- or biotin-conjugated mAb RA3.6B2 (anti-
CD45R, B220), S7 (anti-CD43), GK1.4 (anti-CD4),
53-6.7 (anti-CD8), M1/70 (anti-CD11b, Mac-1), RB6-
8C5 (anti-Ly6G, Gr-1), TER-119 (anti-TER-119), E13-
161.7 (anti-Ly6A/E, Sca-1), 2B8 (anti-CD117, c-Kit),
1D3 (anti-CD19), 53-7.3 (anti-CD5), 17A2 (anti-CD3),
2.4G2 (anti-CD32/CD16 (FcgII/IIIR)), PK136 (anti-
NK1.1) were obtained from BD PharMingen (San
Diego, CA). J11d (anti-CD24, (heat stable antigen)
HSA), CT-CD8a (anti-CD8), CT-CD4 (anti-CD4) and
Streptavidin TC
w were purchased from Caltag labora-
tories (Burlingame, CA).
Immunoﬂuorescence Labeling and FACS Analysis
Immunoﬂuorescence labeling was performed as described
by Lian et al.(1997). Expression of cell surface antigens
was measured by three-color ﬂow cytometry analysis.
Brieﬂy, BMC were aliquoted (10
6) into tubes and
preincubated with CD32/CD16 (Fc Blocke)a t4 8C for
5min. FITC-labeled anti-CD43, CD4 or IgM and
PE-labeled anti-B220, CD19, CD5, HSA or c-kit together
with biotin-labeled anti-CD3, TcR-ab, Thy1.2, Mac-1,
Gr-1, NK1.1, Sca-1, CD4, CD8 or B220 were added
directly to cells in Fc Blocke at 48C for 30min. Cells
were then washed and subsequently incubated with
streptavidin TRI
w. The frequency of cells expressing
individual and/or sets of cell surface markers and the mean
density of expression of such markers was determined by
analysis of a minimum of 50,000 cells utilizing a
FACScan ﬂow cytometer (Becton Dickinson) and Cell
Quest software.
NZB bone marrow B lineage cells can be divided
into distinct maturational stages based on surface
staining for CD43 and sIgM or HSA as reported by
Hardy and Hayakawa (1991). The maturational subsets
are identiﬁed alphabetically and represent increasing
stages of differentiation from the Pre–Pro B cell subset
stage (Fr. A: B220
þCD43
þHSA
2CD19
2) ! Pro-B cell
subset stage (Fr. B–C: B220
þCD43
þHSA
þCD19
þ) !
Pre-B cell subset stage (Fr. D: B220
þCD43
2sIgM
2
CD19
þ) and immature B cell subset stage (Fr. E–F:
B220
þCD43
2sIgM
þCD19
þ) as noted in Fig. 1. We
speciﬁcally quantitated NK1.1
þ cells in the Pre–Pro B
cell population of NZB, BALB/c and C57BL/6 mice,
based on earlier work suggesting that NK1.1
þ cells may
be a minor population in the Pre–Pro B population
(Rolink et al., 1996).
Depletion of Immature/Pre/Pro (Fr. B–F) B Cells
BMC were collected and layered onto a NycoPrepe
(NycoMed Pharma As, Oslo, Norway) discontinuous
density gradient. After centrifugation at 800g for 25min,
cells with a density of 1:066 , p , 1:077 were collected
(Lian et al., 1999). The low-density cells were treated with
a mixture of rat mAbs against mouse sIgM, CD24 (HSA)
and CD19 followed by incubation with anti-rat IgG-
conjugated magnetic-beads (Dynabeads
w). Passage
through a magnetic ﬁeld was utilized to deplete the
Immature/Pre/Pro B (Fr. B–F) cells.
FIGURE 1 Flow cytometric analysis of bone marrow showing identiﬁcation of B lineage subsets in NZB mice. CD45R (B220)
þCD43
þ (R2: Fr. A–C)
were resolved into the Pro-B cell subset (Fr. B–C) and the Pre–Pro B cell subset (Fr. A) based on expression of HSA. CD45R (B220)
þCD43
2 cells
(R1: Fr. D–F) were resolved into Immature B cells (Fr. E–F) and Pre-B cell subsets (Fr. D) based on the expression of IgM.
Z.-X. LIAN et al. 36Cell Cycle Analysis
Cell cycling was detected by the BrdU Flow Kit (BD
PharMingen, San Diego, CA). Micewere injected i.p. with
1mg BrdU dissolved in PBS and were thereafter fed
drinking water containing 1mg/ml BrdU for different
periods of time. The drinking water was light protected
and replaced with fresh BrdU-containing water every
2 days. Brieﬂy, puriﬁed IgM
2/HSA
2/CD 19
2 BMC were
stained with PE-anti B220 mAb, ﬁxed with Cytoﬁx/Cy-
toperm Buffer, and permeabilized with Cytoperm Plus
Buffer. Cells were then incubated again with Cytoﬁx/Cy-
toperm Buffer, followed by treatment with DNase to
expose the BrdU epitopes. Finally, immunoﬂuorescent
staining was performed with FITC conjugated anti-BrdU
(for deﬁning the frequency of dividing cells) and 7-AAD
(for measurement of total DNA content), and analyzed by
FACScan.
Detection of Apoptotic Cells
The frequency of Pre–Pro B (Fr. A) cells undergoing
apoptosis was detected by Annexin V staining (BD
PharMingen, San Diego, CA). After depletion of
Immature/Pre/Pro (Fr. B–F) B cells, 5 £ 10
5 IgM
2/
HSA
2/CD19
2 fresh or cultured cells were resuspended
in binding buffer (10nM HEPES/NaOH, pH 7.4,
140mM NaCl, and 2.5nM CaCl2). Thence, the cells
were incubated with PE-conjugated Annexin V for
15min at room temperature in the dark, washed and
analyzed using the FACScan.
RNA Isolation and Reverse Transcription PCR
Total RNA for cDNA synthesis was prepared from
freshly enriched Pre–Pro B (Fr. A) cells as described
above. Brieﬂy, the low-density Immature/Pre/Pro (Fr.
B–F) B cells (sIgM
þ, HSA
þ, CD19
þ) were ﬁrst
depleted using Dyna magnetic beads. Such enriched
Lin
2 cells were subsequently incubated with CD45R
(B220) microbeads and subjected to further enrichment
using a cell sorter (Miltenyi Biotec Inc., Auburn, CA).
The resulting B220
þ Pre–Pro B cells had a purity
greater than 95% (Fig. 2). RNA was extracted utilizing
the RNAeasy Mini kit (QIAGEN Inc., Santa Clarita,
CA) and eluted into DEPC-treated H2O and stored at
2708C. This RNA was used to synthesize ﬁrst strand
cDNA using Superscript II reverse transcriptase (RT;
GIBCO life Technologies, Gaithersburg, MD), 1mM
dNTPs, 1mg random hexameric oligonucleotides, and
the supplied RT buffer (GIBCO BRL). PCR assays were
carried out using the following primer pairs: b-actin,
50-CCT AAG GCC AAC CGT GAA AAG, 50-TCT TCA
TGG TGC TAG GAG CCA; m0,5 0-AAC ATC TGA
GTT TCT GAG GCT TGG, 50-TCA TCT GAA CCT
TCA AGG ATG CTC; E2A,5 0-CAT CCA TGT CCT
GCG AAG CCA, 50-TTC TTG TCC TCT TCG GCG
TC; Id,5 0-TCC AAC TTC TTG TTC TCT TCC C,
50-CAC AAG ATG CGA TCG TCG; BSAP, 50-TCC
TCG GAC CAT CAG GAC AG, 50-CCT GTT GAT
GGA GCT GAC GC; l5,5 0-CTT GAG GGT CAA TGA
AGC TCA GAG TA, 50-CTT GGG CTG ACC TAG
GAT TG; mb-1,5 0-GCC AGG GGG TCT AGA AGC,
FIGURE 2 Whole BMC from NZB micewere enriched after discontinuous density gradent centrifugation; the low-density IgM
þ, HSA
þ, CD19
þ cells
were ﬁrst depleted using Dyna magnetic beads. Such enriched Lin
2 cells were subsequently incubated with CD45R (B220) microbeads and subjected to
further enrichment using a cell sorter. The resulting B220
þ Pre–Pro B cells had a purity greater than 95%.
PRE–PRO B CELLS IN NZB MICE 3750-TCA CTT GGC ACC CAG TAC AA; B29,50-TAA
GTC TAG AAG TTC CGT GCC ACA GCT GTC,
50-CAC TGA ATT CCC AAG GAA GCC CTT GTT
CCC; Bcl-Xl,5 0-TGA TTC CCA TGG CAG CAG TGA,
50-AAC CAC ACC AGC CAC AGT CAT-30.
Statistical Analysis
Values were determined to be statistically signiﬁcant by
ANOVA test or by unpaired Student’s t-test.
RESULTS
Bone Marrow B Cell Subset Changes
In order to determine the frequency and absolute number
of cells at various stages of B cell development in NZB
mice of different ages, bone marrow samples from 1, 2, 4
and 8 month old mice were examined. As shown in Fig. 3,
the frequency and absolute numbers of cells in fractions
B–Fdecreasedwithage.By8monthsofage,theproportion
(and number) of Immature B cells (Fr. E–F) decreased
from 6.1 to 2.2% (3.0 £ 10
6 to 1.1 £ 10
6), Pre-B cells
(Fr. D) from 11.6 to 3.2% (5.8 £ 10
6 to 1.5 £ 10
6) and
Pro-B cells (Fr. B–C) decreased from 4.3 to 0.2%
(2.1 £ 10
6 to 0.5 £ 10
6). In contrast, there was a marked
increase in the frequency (from 3.6 to 6.7%) and absolute
numbers (1.8 £ 10
6 to 2.7 £ 10
6) of Pre–Pro B cells
(Fr. A) from 1 to 2 months of age. Pre–Pro B cells at
8 months of age, however, showed an age associated
decline, but still remained higher than levels at 1 month
of age.
As shown in Fig. 4A, a similar analysis of B cell
differentiation in BALB/c, C3H, and C57BL/6 mice
demonstrated that the trend was unique to NZB mice. The
data in Fig. 4 also show that the decline in the frequency
and absolute number of immature and Pre-B cells in bone
marrow of NZB mice is greater than that seen in normal
mice. Unexpectedly, the Pre–Pro B cell populations are
unusually expanded in NZB mice, and signiﬁcantly higher
at 8 months in comparison with control mice (Fig. 4D).
It has been previously reported that NK1.1
þ cells may be
included in a minor population of a Pre–Pro B cell
population (Rolink et al., 1996). In preliminary experi-
ments, we detected a similar frequency of NK1.1
þ Pre–
Pro B cells in age-matched NZB mice and C57BL/6 mice.
However, NK1.1 are not expressed in BALB/c mice (data
not shown). Further, the NK1.1 population was depleted
before our analysis.
BrdU Labeling of Pre–Pro B Cells
It was reasoned that the increased number of Pre–Pro
B cells in the bone marrow of NZB mice could be
secondary to an increased level of proliferation of cells at
this stage of B cell maturation. In order to examine this
possibility, we analyzed the percentages of BrdU
þ Pre–
Pro B cells in bone marrow from NZB, and for com-
parison, BALB/C and C57BL/6 mice. Attempts were
made in initial experiments to assess the frequency of
BrdU
þ Pre–Pro B cells in unfractionated bone marrow,
but the low numbers of Pre–Pro B cells made this analysis
difﬁcult. Therefore, after low-density cell isolation, the
IgM
þ/HSA
þ/CD19
þ BMC were depleted using magnetic
beads as described in the “Materials and Methods”
section, prior to analysis (Fig. 5). As shown in Fig. 6 and
Table I, the frequency of BrdU
þ cells in NZB Pre–Pro B
cells is lower than in normal mice. Two hours after the
injection of BrdU, only 0.9% of the Pre–Pro B cells were
BrdU
þ in the NZB mice, while almost 2% of the Pre–Pro
B cells from BALB/c mice were BrdU
þ. In addition,
while 90% of Pre–Pro B cells in control micewere BrdU
þ
FIGURE 3 Age-related changes in the absolute number (A) and frequency (B) of B lineage subsets in NZB bone marrow. The average percentages
amongall nucleatedcells and numbersper femurs andtibiaewere determinedby analyzingindividual animalsaged 1, 2, 4 and 8 monthsin three separate
experiments. Statistical signiﬁcance was determined by analysis of variance (ANOVA) with comparison to 1-month old BMC. *p ,0:05; **p ,0:01;
***p ,0:001:
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in NZB mice were BrdU
þ (Table I). These data suggest
that increased proliferation does not account for the
increased frequency and absolute numbers of Pre–Pro B
cells in the bone marrow of NZB mice.
The Rate of Pre–Pro B Cell Apoptosis in NZB Mice
The increased frequency of bone marrow Pre–Pro B cells
in NZB mice could also be due to the increased survival of
cells at this stage, resulting in an accumulation of cells in
that compartment relative to normal mice. To address this
issue, the frequency of cells undergoing spontaneous
apoptosis was measured. The data in Fig. 7 show results
from one of four representative experiments where the
frequency of apoptotic Pre–Pro B cells was determined.
Highlyenrichedpopulations of Pre–Pro B cells from adult
NZB mice exhibited a much lower level of apoptosis
ð3:45 ^ 0:23%Þ than similar preparations of cells from
similarly aged BALB/c ð9:1 ^ 1:8%Þ; and C57BL/6
mice ð6:2 ^ 1:3%Þ (Table II). Because apoptotic cells
are rapidly removed from the bone marrow, the number of
such cells detectable at any one time is low (Lu et al.,
1998). Therefore, a short-term culture system that allows
for the accumulation and enumeration of apoptotic cells
was used. IgM
þ/HSA
þ/CD19
þ depleted low-density
BMC from similarly aged adult NZB and normal
BALB/c mice were incubated for 24h, and apoptosis
was examined by Annexin V staining. Once again, the
frequency of apoptotic Pre–Pro B cells in NZB mice was
found to be markedly lower than in normal BALB/c mice
(Fig. 7 and Table II). In addition, the ﬁnding that the
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higher than normal BALB/c mice (Fig. 8), supports the
view that Pre–Pro B cells from NZB mice are relatively
resistant to undergo apoptosis and, therefore, reﬂects a
longer half-life of B cells at this stage of maturation.
Gene Expression in Pre–Pro B Cells
To further clarify the mechanisms responsible for the
abnormal accumulation of Pre–Pro B cells in NZB mice,
we examined the expression of key B cell lineage genes
involved in the process of B cell maturation and differen-
tiation using a highly enriched population of Pre–Pro B
cells from the bone marrow of 2-month-old NZB and age
matched control normal BALB/c mice prepared as
described. Figure 8 illustrates that the expression of the
transcription factor BSAP in Pre–Pro B cells of NZB mice
was down regulated, as were Iga (mb-1) and the Igb (B29)
genes. Levels of the expression of the surrogate light chain
l5 and Rag-2 were also lower in Pre–Pro B cells from
NZB mice relative to levels seen in similar cells from
control mice.
DISCUSSION
NZB mice, as well as severalother models of murine lupus
models manifest abnormal patterns of B-lineage cell
FIGURE 4 Comparison of proportion and numbers of (A): B cell (Fr. E–F), (B): Pre-B cell (Fr. D), (C): Pro-B cell (Fr. B–C), and (D): Pre–Pro B cell
(Fr. A) between NZB mice and normal inbred strains. *p ,0:05; **p ,0:01; ***p ,0:001 analysis of variance (ANOVA) with comparison to NZB
mice.
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exhibit accelerated appearance and production of B
lineage precursor cells during fetal and neonatal life
(Jyonouchi et al., 1983; Jyonouchi and Kincade, 1984).
NZB mice develop large numbers of B cell precursors at
an early stage of embryonic development, suggesting that
hyperactive B cell formation continues for the ﬁrst few
weeks of life. By 5–6 months of age, however, the fre-
quency and absolute numbers of Pre-B cells are markedly
reduced when compared with age-matched normal murine
strains (Jyonouchi et al., 1982; Kruger and Riley, 1990).
Merchant et al. (1995; 1996) localized the decreases in
the differentiation and maturation of B lineage cells to the
Pre-B and immature B cell stages. However, it was not
clear whether this decrease was manifest throughout the
currently recognized stages of B cell maturation or ini-
tiated at the Pre-B or Pre–Pro B cell stage. Herein, we ﬁnd
that in fact there is an increase in the frequency of Pre–Pro
B cells in the BM of NZB; this increase was most
pronounced at 1 month of age and is sustained throughout
the ages of the NZB mice studied, suggesting that there is
a block in the maturation of B cells at the Pre–Pro B cell
stage that leads to an accumulation of these cells with
an associated decrease in the frequencies of the
subsequent stages of B cell maturation. Rolink et al.
have reported that NK1.1
þ cells may be included within
FIGURE 5 Whole BMC from NZB mice were enriched after discontinuous density gradent centrifugation; IgM
þ and HSA
þ cells were depleted by
magnetic-beads as described in the “Materials and Methods” section. Note the high frequency of the Pre–Pro B cell subset (R1). A similar depletion was
demonstrated with the control strains (data not shown).
FIGURE 6 Cell cycle analysis of the Pre–Pro B cell frequency that
have incorporated BrdU and total DNA. Data are representative of one of
four experiments using a total of 2–4 mice per group.
PRE–PRO B CELLS IN NZB MICE 41Pre–Pro B cells (Rolink et al., 1996). As noted above, we
found a similar frequency of NK1.1
þ cells in age-matched
NZB and C57BL/6 mice. They are not expressed in
BALB/c mice.
Numerous studies have described that allogeneic bone
marrow transplantation (BMT) can be disease preventive
and has been attempted for the treatment of both systemic
and organ-speciﬁc autoimmune diseases in SLE models
(Ikehara et al., 1985; Ishida et al., 1994; Adachi et al.,
1995; Mizutani et al., 1995; Ikehara, 1998; Good, 2000;
Good and Verjee, 2001). More recently, we have reported
that stem cells from adult NZB mouse bone marrow
exhibited defective T cell lineage development in fetal
thymic organ culture (FTOC) (Hashimoto et al., 2000).
These ﬁndings suggest that autoimmune disease originates
from intrinsic disorders of the HSCs themselves and in
their developmental pathways, followed by autoreactive
lymphocyte accumulation (Ikehara et al., 1990; Ikehara,
2001). Our observation of an unusual expansion of Pre–
Pro B cells in NZB mice is consistent with these studies.
It is believed that immune “tolerance” is accomplished,
in part, through an educational phase of B lymphocyte
development: autoreactive B cells are identiﬁed at an early
maturational stage and effectively silenced. Importantly,
depletion of immature B cells has been shown by studies
that evaluated the numbers of cells that successfully
traverse the immature to mature B cell stage of develop-
ment daily (Lu and Osmond, 2000). The data indicate a
high apoptotic index at the Pre–Pro B/Pro-B transition,
many Pre–Pro B cells normally generate non-productive
rearrangements and are diverted into a programmed cell
death pathway. Our observation demonstrates that the
level of spontaneous apoptosis of fresh and cultured Pre–
Pro B cells in NZB mice are signiﬁcantly lower than in
normal mice, suggesting that some autoreactive B cells
may escape from apoptosis to continue the maturation
process. The general defect in apoptosis implicates the
maturational arrest of the B cells in the pathogenesis of
autoimmunity in NZB mice.
There are several mechanism(s) that either individually
or in concert could account for the accumulation of the B
lineage cells at the Pre–Pro B cell stage. These include
prolonged persistence and half-life of cells at this stage of
maturation, decreased sensitivity to undergo apoptosis
(increased half-life) or dysregulation of genes that control
TABLE I Expression of BrdU in Pre–Pro B Cells from NZB and
Control Mice
BrdU
þ
2h 7 Days
NZB 0.89 ^ 0.11 56.95 ^ 0.95
BALB/c 1.94 ^ 0.26* 87.95 ^ 0.37*
C57BL/6 ND 84.32 ^ 0.56*
The results from four separate experiments are presented. *p ,0:001 ANOVA test,
ND: not done.
FIGURE 7 Frequency of Pre–Pro B cells from NZB, BALB/c mice and C57BL/6 mice undergoing spontaneous (i–iii) or following in vitro culture
(iv–vi) apoptosis. Pre–Pro B cells were puriﬁed with magnetic-beads and ﬂow cytometry proﬁles of Pre–Pro B cells (R1) and Annexin V expression
histograms obtained of Pre–Pro B cells before or after 18h following invitro culture. Data are representative of one of three experiments using a total of
2–4 mice per group.
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demonstrated, the Pre–Pro B cells of NZB mice exhibit
a much slower turnover rate and prolonged persistence,
and resistance to apoptosis as compared to normal mice.
The dysregulation of genes controlling B cell diffe-
rentiation/development is another facet of the abnormal
Pre–Pro B cell population expansion. Essential to
the understanding of the molecular basis of this pathology
is the clear characterization of the rearrangement status of
the immunoglobulin heavy chain (IgH) locus (Hardy and
Hayakawa, 1991; 2001; Li et al., 1993; 1996). The
expression of m is one of the earliest indication of B cell
lineage commitment (Alessandrini and Desiderio, 1991;
Schlissel et al., 1991), reﬂecting the remodeling of
chromatin structure to make the heavy chain locus
accessible to rearrangements (Alt et al., 1987). Transcripts
of Rag-1 and Rag-2 gene are essential to IgH
rearrangement; Pre–Pro B cells possess very low levels
of mRNA from Rag-1 and Rag-2 genes and very little
immunoglobulin D-J heavy chain rearrangement (Hardy
and Hayakawa, 1991; Ehlich et al., 1993; Li et al., 1993).
In this study, there was normal expression of the m0
transcript in NZB mice, but Rag-2 transcript was
decreased in the Pre–Pro B fraction in NZB mice
compared with normal mice, suggesting impairment of
rearrangement in the Pre–Pro B fraction in the NZB mice.
The initiation of B-cell development critically depends
on several transcription factors. B-cell-speciﬁc activator
protein (BSAP, also termed B-lymphoid-speciﬁc tran-
scription factor pax5) has been shown to play an essential
role in early B cell development (Nutt et al., 1999a,b). The
absence of BSAP leads to an arrest in B cell development
at the earliest stage before rearrangement of the IgH
(Urbanek et al., 1994) occurs. It has been shown that loss
of BSAP affects the B lymphoid-restricted VH -to-DHJH
joining step of IgH assembly (Nutt et al., 1997). BSAP
appears to play a crucial role in B-lineage commitment
(Nutt et al., 1999a). In our experiments, impairment of
BSAP was observed in NZB Pre–Pro B cells, supporting
the thesis that dysregulation of the cascade of gene
transcription is involved in the abnormality in NZB mice.
The initiation of B cell development also critically
depends on the E2A gene which encodes two helix-loop-
helix transcription factors, E12 and E47. In the absence of
these proteins, B cell development is arrested at the
earliest stage, before DHJH rearrangement of the IgH
chain occurs (Bain et al., 1994; Zhuang et al., 1994; Lin
and Grosschedl, 1995). The level of E2A expression in
Pre–Pro B cells were similar in NZB mice and BALB/c
mice. E2A products are required for BSAP expression
(Bain et al., 1994), and therefore the impairment of BSAP
in NZB mice is not likely due to altered levels of E2A.
It has been suggested that the E2A gene products are
involved in cell lineage commitment while BSAP is
essential for progression of B cell development beyond
the early Pro-B cell stage (Busslinger et al., 2000). It has
also been reported that a decrease in BSAP levels results
in a loss of cell proliferation capability (Chong et al.,
2001), which is in accordance with our ﬁndings that BrdU
incorporation is decreased in the NZB Pre–Pro B cell.
Collectively, an abnormal decrease of BSAP expression
may be responsible for the abnormal increase of the
Pre-Pro B cells in NZB mice. We recognize, however, that
this genetic analysis must be performed on isolated B cell
TABLE II Percentage of Annexin V
þ cells in Pre–Pro B cells
% of apoptosis in Pre–Pro B cells
Strain Before culture After culture
NZB 3.45 ^ 0.23 49.46 ^ 5.35
BALB/c 9.06 ^ 1.77*** 60.76 ^ 8.34*
C57BL/6 6.21 ^ 1.26** 62.05 ^ 8.48*
*p ,0:05; **p ,0:01; ***p ,0:001 Unpaired ANOVA test. Data are representa-
tive of four independent experiments.
FIGURE 8 Expression of mRNA for Bcl-Xl, m0, Rag-2, BSAP, E2A,
Iga. Igb and l5 in sorted B220
þCD43
þCD19
2HSA
2 (Pre–Pro B) cells
from bone marrow of NZB and BALB/c mice. Total RNA isolation and
RT-PCR assays were performed as described in “Material and Methods”
section. Dilutions of cDNA were subjected to PCR ampliﬁcation speciﬁc
for b-actin, Bcl-Xl, m0, Rag-2, BSAP, E2A, Iga. Igb and l5 and the
resulting products separated by electrophoresis on a 1.5% agarose gel
containing ethidium bromide and visualized by UV light illumination.
PRE–PRO B CELLS IN NZB MICE 43subpopulations in a more quantitative fashion. Such work
is in progress.
B cell antigen receptor complexes include membrane-
bound immunoglobulin molecules non-covalently bound
to the Iga and Igb protein, respectively, the products of
the mb-1 and B29 genes (Reth, 1992). In addition, Iga/
Igb heterodimers are essential elements in Pre-B and
B receptor signaling, and the role of Igb in B lympho-
poesis before m heavy chain synthesis has also been
suggested using Igb knockout mice (Benlagha et al.,
1999). A recent report also suggests that signaling through
Igb regulates locus accessibility for ordered Ig gene
rearrangements (Maki et al., 2000). In our study, mb-1 and
B29 were also reduced in NZB mice Pre–Pro B cells. It is
possible that the reduction of mb-1 may be due to the
reduced expression of BSAP because mb-1 is positively
regulated by BSAP (Busslinger et al., 2000).
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